DK230185A - 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf - Google Patents

1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf Download PDF

Info

Publication number
DK230185A
DK230185A DK230185A DK230185A DK230185A DK 230185 A DK230185 A DK 230185A DK 230185 A DK230185 A DK 230185A DK 230185 A DK230185 A DK 230185A DK 230185 A DK230185 A DK 230185A
Authority
DK
Denmark
Prior art keywords
oxazolidin
procedures
derivatives
preparing
Prior art date
Application number
DK230185A
Other languages
English (en)
Other versions
DK165952C (da
DK230185D0 (da
DK165952B (da
Inventor
Mitsuo Masaki
Haruhiko Shinozaki
Masaru Satoh
Naoya Moritoh
Koichi Hashimoto
Toshiro Kamishiro
Original Assignee
Nippon Chemiphar Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Chemiphar Co filed Critical Nippon Chemiphar Co
Publication of DK230185D0 publication Critical patent/DK230185D0/da
Publication of DK230185A publication Critical patent/DK230185A/da
Publication of DK165952B publication Critical patent/DK165952B/da
Application granted granted Critical
Publication of DK165952C publication Critical patent/DK165952C/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/16Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/18Oxygen atoms
    • C07D263/20Oxygen atoms attached in position 2
    • C07D263/22Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK230185A 1984-09-28 1985-05-23 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf DK165952C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP59203624A JPS6183170A (ja) 1984-09-28 1984-09-28 新規な1,3−オキサゾリジン−2−オン誘導体およびその製造法
JP20362484 1984-09-28

Publications (4)

Publication Number Publication Date
DK230185D0 DK230185D0 (da) 1985-05-23
DK230185A true DK230185A (da) 1986-03-29
DK165952B DK165952B (da) 1993-02-15
DK165952C DK165952C (da) 1993-07-05

Family

ID=16477122

Family Applications (1)

Application Number Title Priority Date Filing Date
DK230185A DK165952C (da) 1984-09-28 1985-05-23 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf

Country Status (27)

Country Link
US (1) US4644063A (da)
JP (1) JPS6183170A (da)
KR (1) KR900004323B1 (da)
AR (1) AR240924A1 (da)
AT (1) AT392069B (da)
AU (1) AU566419B2 (da)
BR (1) BR8502707A (da)
CA (1) CA1252092A (da)
CH (1) CH663207A5 (da)
CS (1) CS273606B2 (da)
DE (1) DE3519261C2 (da)
DK (1) DK165952C (da)
ES (2) ES8800571A1 (da)
FR (1) FR2571052B1 (da)
GB (2) GB8512975D0 (da)
HU (1) HU199132B (da)
IN (1) IN162060B (da)
IT (1) IT1208807B (da)
MX (2) MX161397A (da)
MY (1) MY102081A (da)
NL (1) NL193191C (da)
NZ (1) NZ212143A (da)
PH (1) PH20852A (da)
RO (1) RO91422B (da)
SE (1) SE463100B (da)
SU (2) SU1402263A3 (da)
ZA (1) ZA854001B (da)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6183147A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤
JPH0759570B2 (ja) * 1986-05-06 1995-06-28 三井東圧化学株式会社 2−オキサゾリジノン類の製造方法
JPH0713017B2 (ja) * 1986-06-18 1995-02-15 日本ケミファ株式会社 脳細胞保護作用を有する医薬組成物
EP0307141B1 (en) * 1987-09-10 1993-01-13 MERCK SHARP & DOHME LTD. Oxazoles and thiazoles for the treatment of senile dementia
CA1329128C (en) * 1988-03-24 1994-05-03 Nobuyoshi Iwata Isoxazolinones as cerebro-active drugs
JPH0314562A (ja) * 1988-04-11 1991-01-23 Nippon Chemiphar Co Ltd 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤
US5187171A (en) * 1989-01-09 1993-02-16 G. D. Searle & Co. Use of a glycine b partial agonist as an antipsychotic
DK0579169T3 (da) * 1992-07-14 1999-05-31 Nippon Chemiphar Co Alkylendiaminderivater
US5698573A (en) * 1993-09-15 1997-12-16 Merck, Sharp & Dohme, Ltd. Imidazolone and oxazolone derivatives as dopamine antagonists
DE4425613A1 (de) * 1994-07-20 1996-01-25 Bayer Ag 5-gliedrige Heteroaryl-oxazolidinone
US6037354A (en) * 1997-06-18 2000-03-14 Merck & Co., Inc. Alpha 1a adrenergic receptor antagonists
ES2633269T3 (es) 2013-03-14 2017-09-20 Akzo Nobel Chemicals International B.V. Éter de celulosa como agente de control de dispersión y agente de resistencia a la lluvia

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2437389A (en) * 1948-03-09 Oxazoeidones and erocesstok
DE1135461B (de) * 1959-05-08 1962-08-30 Knoll Ag Verfahren zur Herstellung von basisch substituierten Phthalimidinen
FR1301267A (fr) * 1961-04-04 1962-08-17 Science Union Et Compagnie Soc Nouveaux dérivés de l'oxazolidinone-2 et leurs procédés de préparation
US3131197A (en) * 1963-03-13 1964-04-28 Smith Kline French Lab 5-(3, 4-carbonyldioxyphenyl)-3-isopropyl-2-oxazolidone
US3576808A (en) * 1967-09-15 1971-04-27 Miles Lab N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones
GB1222708A (en) * 1968-10-22 1971-02-17 Delalande Sa Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation
FR2179582B1 (da) * 1972-04-13 1975-10-10 Synthelabo

Also Published As

Publication number Publication date
CS392785A2 (en) 1990-08-14
NZ212143A (en) 1987-11-27
GB2165237A (en) 1986-04-09
MX161397A (es) 1990-09-20
FR2571052A1 (fr) 1986-04-04
US4644063A (en) 1987-02-17
SE8502525L (sv) 1986-03-29
MX21592A (es) 1994-01-31
DE3519261C2 (de) 1997-01-16
JPS6183170A (ja) 1986-04-26
AU4469785A (en) 1986-04-10
HUT39168A (en) 1986-08-28
FR2571052B1 (fr) 1988-03-04
NL193191B (nl) 1998-10-01
ES8800571A1 (es) 1987-11-01
RO91422A (ro) 1987-06-30
SU1431679A3 (ru) 1988-10-15
SE463100B (sv) 1990-10-08
ES543517A0 (es) 1987-11-01
DK165952C (da) 1993-07-05
NL193191C (nl) 1999-02-02
ES8802152A1 (es) 1988-04-01
ZA854001B (en) 1986-01-29
CA1252092A (en) 1989-04-04
PH20852A (en) 1987-05-19
DK230185D0 (da) 1985-05-23
IT8567500A0 (it) 1985-05-30
HU199132B (en) 1990-01-29
DE3519261A1 (de) 1986-04-10
BR8502707A (pt) 1986-05-27
CH663207A5 (fr) 1987-11-30
GB8513685D0 (en) 1985-07-03
IN162060B (da) 1988-03-19
ES557075A0 (es) 1988-04-01
GB8512975D0 (en) 1985-06-26
DK165952B (da) 1993-02-15
SU1402263A3 (ru) 1988-06-07
RO91422B (ro) 1987-07-02
AR240924A2 (es) 1991-03-27
SE8502525D0 (sv) 1985-05-22
AU566419B2 (en) 1987-10-22
CS273606B2 (en) 1991-03-12
AT392069B (de) 1991-01-25
KR900004323B1 (ko) 1990-06-22
KR860002502A (ko) 1986-04-26
GB2165237B (en) 1987-12-09
IT1208807B (it) 1989-07-10
JPH0469150B2 (da) 1992-11-05
NL8501579A (nl) 1986-04-16
ATA165685A (de) 1990-07-15
MY102081A (en) 1992-03-31
AR240924A1 (es) 1991-03-27

Similar Documents

Publication Publication Date Title
DK381485A (da) 1,2-benzisothiazol-3-yl-piperazinderivater og fremgangsmaade til fremstilling deraf
DK577084D0 (da) 2,2'iminobisethanol-derivater og fremgangsmaade til fremstilling deraf
NO860190L (no) Peptid-derivater og fremgangsmaate for fremstilling derav.
DK574581A (da) Delta2-1,2,4-triazolin-5-on-derivater og fremgangsmaade til fremstilling heraf
DK316784D0 (da) 1,2,4-triazol-3-on-derivater og fremgangsmaade til fremstilling deraf
DK437286D0 (da) 2,5-diaryl-tetrahydrothiophenforbindelse og fremgangsmaade til fremstilling deraf
DK385884A (da) 2,6-substituerede 3,5-pyridin-dicarboxylsyre-derivater og fremgangsmaade til fremstilling heraf
DK468284D0 (da) 1,2,4-triazolonderivater og fremgangsmaade til fremstilling deraf
DK207785D0 (da) Indolin- og 2-indolinon-derivater og fremgangsmaade til fremstilling deraf
NO855026L (no) Aminoacyllabdaner og fremgangsmaate til fremstilling derav.
DK315085D0 (da) Isoinsolinyl-alkyl-piperaziner og fremgangsmaade til fremstilling deraf
DK165952C (da) 1,3-oxazolidin-2-on-derivater og fremgangsmaade til fremstilling heraf
DK477287A (da) Pyrido-benzoxadiazin-derivater og fremgangsmaade til fremstilling deraf
DK217388D0 (da) 1,3-dioxaner og fremgangsmaade til fremstilling deraf
DK52885A (da) 1,3,2-dioxaborinan-forbindelser og fremgangsmaade til fremstilling heraf
DK357385D0 (da) Dihydropyridin-derivater og fremgangsmaade til fremstilling deraf
DK401385A (da) 7-oxomitosan-derivater og fremgangsmaade til fremstilling deraf
DK79485A (da) 2-arylimidazo(4,5-c)pyridiner og fremgangsmaade til fremstilling heraf
DK446685D0 (da) Carbapenemderivater og fremgangsmaade til fremstilling deraf
NO893963L (no) 3-aryloksymetyl-cefalosporinderivater og fremgangsmaate til fremstilling derav.
DK182585D0 (da) Fosfomycinderivat og fremgangsmaade til fremstilling deraf
DK14685A (da) Thioketenderivater og fremgangsmaade til fremstilling deraf
DK282885D0 (da) 3,4-diamino-1,2,5-thiadiazol-derivater og fremgangsmaade til fremstilling deraf
DK191982A (da) 2,4-dioxacyklohexanonderivat og fremgangsmaade til fremstilling deraf
DK287787D0 (da) Isoxazolidinonderivater og fremgangsmaade til fremstilling deraf

Legal Events

Date Code Title Description
PBP Patent lapsed